Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands

被引：8

作者：

Chen, XQ ^{[1
]}

Kempf, DJ ^{[1
]}

Sham, HL ^{[1
]}

Green, BE ^{[1
]}

Molla, A ^{[1
]}

Korneyeva, M ^{[1
]}

Vasavanonda, S ^{[1
]}

Wideburg, NE ^{[1
]}

Saldivar, A ^{[1
]}

Marsh, KC ^{[1
]}

McDonald, E ^{[1
]}

Norbeck, DW ^{[1
]}

机构：

[1] Abbott Labs, Div Pharmaceut Prod, Abbott Pk, IL 60064 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 24期

关键词：

D O I：

10.1016/S0960-894X(98)00653-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The 2-isopropyl thiazolyl group is a highly optimized P-3 ligand for C-2 symmetry-based HIV protease inhibitors, as exemplified in the drug ritonavir. Here we report that incorporation of this P-3 ligand into a piperazine hydroxyethylamine series also yielded novel, highly potent inhibitors. In tissue culture assays, the presence of human serum was less deleterious to the activity of these inhibitors than to that of ritonavir. Furthermore, potent activity against ritonavir resistant HIV was observed. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：3531 / 3536

页数：6

共 19 条

[1]

ASKIN D, 1995, Patent No. 02583

[2]

ASKIN D, 1995, Patent No. 02584

[3] Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].

Cameron, DW ;

Heath-Chiozzi, M ;

Danner, S ;

Cohen, C ;

Kravcik, S ;

Maurath, C ;

Sun, E ;

Henry, D ;

Rode, R ;

Potthoff, A ;

Leonard, J .

LANCET, 1998, 351 (9102) :543-549

[4] Evaluation of furofuran as a P-2 ligand for symmetry-based HIV protease inhibitors [J].

Chen, XQ ;

Li, L ;

Kempf, DJ ;

Sham, H ;

Wideburg, NE ;

Saldivar, A ;

Vasavanonda, S ;

Marsh, KC ;

McDonald, E ;

Norbeck, DW .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (23) :2847-2852

[5] L-735,524 - THE DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR [J].

DORSEY, BD ;

LEVIN, RB ;

MCDANIEL, SL ;

VACCA, JP ;

GUARE, JP ;

DARKE, PL ;

ZUGAY, JA ;

EMINI, EA ;

SCHLEIF, WA ;

QUINTERO, JC ;

LIN, JH ;

CHEN, IW ;

HOLLOWAY, MK ;

FITZGERALD, PMD ;

AXEL, MG ;

OSTOVIC, D ;

ANDERSON, PS ;

HUFF, JR .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (21) :3443-3451

[6] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].

Hammer, SM ;

Squires, KE ;

Hughes, MD ;

Grimes, JM ;

Demeter, LM ;

Currier, JS ;

Eron, JJ ;

Feinberg, JE ;

Balfour, HH ;

Dayton, LR ;

Chodakewitz, JA ;

Fischl, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733

[7] Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy [J].

Kempf, DJ ;

Sham, HL ;

Marsh, KC ;

Flentge, CA ;

Betebenner, D ;

Green, BE ;

McDonald, E ;

Vasavanonda, S ;

Saldivar, A ;

Wideburg, NE ;

Kati, WM ;

Ruiz, L ;

Zhao, C ;

Fino, LM ;

Patterson, J ;

Molla, A ;

Plattner, JJ ;

Norbeck, DW .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (04) :602-617

[8] ANTIVIRAL AND PHARMACOKINETIC PROPERTIES OF C2 SYMMETRICAL INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE [J].

KEMPF, DJ ;

MARSH, KC ;

PAUL, DA ;

KNIGGE, MF ;

NORBECK, DW ;

KOHLBRENNER, WE ;

CODACOVI, L ;

VASAVANONDA, S ;

BRYANT, P ;

WANG, XC ;

WIDEBURG, NE ;

CLEMENT, JJ ;

PLATTNER, JJ ;

ERICKSON, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2209-2214

[9] EVALUATION OF SUBSTITUTED BENZAMIDES AS P2 LIGANDS FOR SYMMETRY-BASED INHIBITORS OF HIV PROTEASE [J].

KEMPF, DJ ;

FLENTGE, CA ;

WIDEBURG, NE ;

SALDIVAR, A ;

VASAVANONDA, S ;

NORBECK, DW .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (22) :2725-2728

[10] ABT-538 IS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE AND HAS HIGH ORAL BIOAVAILABILITY IN HUMANS [J].

KEMPF, DJ ;

MARSH, KC ;

DENISSEN, JF ;

MCDONALD, E ;

VASAVANONDA, S ;

FLENTGE, CA ;

GREEN, BE ;

FINO, L ;

PARK, CH ;

KONG, XP ;

WIDEBURG, NE ;

SALDIVAR, A ;

RUIZ, L ;

KATI, WM ;

SHAM, HL ;

ROBINS, T ;

STEWART, KD ;

HSU, A ;

PLATTNER, JJ ;

LEONARD, JM ;

NORBECK, DW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2484-2488

← 1 2 →